par Bozovic, Ivana 
;Abdel Azim, Hatem Hamdy ;Paesmans, Marianne ;Suter, Thomas;Piccart-Gebhart, Martine ;de Azambuja, Evandro
Référence Lancet oncology, 12, 3, page (209-211)
Publication Publié, 2011-03
;Abdel Azim, Hatem Hamdy ;Paesmans, Marianne ;Suter, Thomas;Piccart-Gebhart, Martine ;de Azambuja, Evandro Référence Lancet oncology, 12, 3, page (209-211)
Publication Publié, 2011-03
Article révisé par les pairs
| Titre: |
|
| Auteur: | Bozovic, Ivana; Abdel Azim, Hatem Hamdy; Paesmans, Marianne; Suter, Thomas; Piccart-Gebhart, Martine; de Azambuja, Evandro |
| Informations sur la publication: | Lancet oncology, 12, 3, page (209-211) |
| Statut de publication: | Publié, 2011-03 |
| Sujet CREF: | Cancérologie |
| MeSH keywords: | Anthracyclines -- administration & dosage |
| Antibodies, Monoclonal -- administration & dosage | |
| Antibodies, Monoclonal, Humanized | |
| Antineoplastic Agents -- administration & dosage | |
| Breast Neoplasms -- drug therapy -- metabolism | |
| Drug Therapy, Combination | |
| Female | |
| Humans | |
| Neoadjuvant Therapy | |
| Receptor, erbB-2 | |
| Note générale: | Journal Article |
| SCOPUS: le.j | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:1470-2045 |
| info:doi/10.1016/S1470-2045(11)70013-4 | |
| info:pii/S1470-2045(11)70013-4 | |
| info:scp/79952043612 | |
| info:pmid/21354372 |
